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The present study investigated the early presence of inﬂammatory response in renal tissue of young
offspring from diabetic mothers. The effect of L-arginine (L-arg) supplementation was also investigated.
The offspring was divided into four groups: group CO (controls); group DO (diabetic offspring); group
CA (CO receiving 2% L-arg solution) and group DA (DO receiving the 2% L-arg solution). Glycemia,
arterial pressure and renal function were evaluated; gene and protein expression of pro-inﬂammatory
cytokines were also measured. Blood pressure levels were signiﬁcantly increased in 2 and 6 month-old
DO rats, whereas L-arg administration caused a signiﬁcant decrease in the DA group, at both ages. DO
rats showed a signiﬁcantly blunted glycemic response to exogenous insulin. In 2 month-old DO
animals, renal protein expression of pro-inﬂammatory molecules was signiﬁcantly increased. At six
months of age, we also observed an increase in gene expression of pro-inﬂammatory molecules,
whereas L-arg supplementation prevented this increase at both ages. Our data suggest that activation of
inﬂammatory pathways is present early in the kidney of DO rats, and that L-arg can attenuate the
expression of these markers of tissue inﬂammation. Our results also reinforce the concept that
intrauterine environmental factors are a fundamental determinant in the development of metabolic
and vascular diseases later in life.
& 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Gestational diabetes mellitus can impose several threats both
to the mother and to the conceptus. Diabetic pregnancy increases
the risk of intrauterine death, prematurity, perinatal mortality
and congenital malformations (Lynch and Wright, 1997;
Martinez-Frias, 1994; Nold and Georgieff, 2004). It has also been
demonstrated by both epidemiological and experimental studies
that the offspring of diabetic mothers has an increased risk for
development of cardiovascular disease and insulin resistance in
adulthood (Boloker et al., 2002; Carlsson et al., 1999; Holemansparo a Pesquisa do Estado de
7782-3, 2012/02270-2 and
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sevier OA license.et al., 1999; Manderson et al., 2002; Pettitt et al., 1983). In
previous studies, we have demonstrated that maternal diabetes
promotes remarkable changes in kidney morphology and function
and in vascular reactivity in mature offspring (Rocha et al., 2005).
In young animals, we found an altered response to a glucose
tolerance test and an inability to excrete a salt overload (Magaton
et al., 2007; Rocco et al., 2008). Our previous study showed that in
the diabetic offspring model, the early onset of hypertension was,
at least partially, related to an insufﬁcient basal production of
nitric oxide (NO), since after the administration of L-arginine
(L-arg) blood pressure levels and vascular reactivity returned to
normal levels (Cavanal Mde et al., 2007).
Activation of inﬂammatory pathways has been demonstrated
in several pathologies, among them metabolic and cardiovascular
diseases. Insulin resistance, impaired endothelium-dependent
relaxation and up-regulation of inﬂammatory markers were
shown to be present in spontaneously hypertensive rats (SHR)
and in a salt-sensitive model of hypertension, the Dahl rats
(Delano et al., 2010; Potenza et al., 2005; Zhou et al., 2010). In
these hypertensive states, free radical production is enhanced
(DeLano et al., 2005; Swei et al., 1999). On the other hand,
alterations in NO synthase (NOS) isoforms in brain and kidney
M. Correa-Costa et al. / European Journal of Pharmacology 689 (2012) 233–240234of rats with genetic and salt-induced hypertension were shown
by Hojna et al. (2010). Therefore, in the present study, we
hypothesized that inﬂammatory response can be detected early
in renal tissue of young DO rats, and in mature DO animals, this
inﬂammatory response could be even enhanced. Since L-arg has
been shown to attenuate both renal injury and hypertension in
DO group (Cavanal Mde et al., 2007), the role of L-arg was also
investigated in our study.2. Materials and methods
All procedures used in this study were approved and per-
formed in accordance with the guidelines of the Ethics Committee
of Biomedical Institute, Federal University of S~ao Paulo (document
number 0518/06) and were conducted following the Guide for
Care and Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication no. 85-23, revised 1996).
Wistar rats from our colony (Federal University of S~ao Paulo)
were maintained in a room at 2271 1C with a 12 h light cycle and
60% humidity.
2.1. Animal model
Diabetes mellitus was induced by streptozotocin, (50 mg/kg),
given by a single intraperitoneal injection to female Wistar rats
(250–300 g). Control animals were given an equivalent amount of
citrate buffer. Diabetic state was conﬁrmed 48 h after, by measur-
ing blood glucose. Only those animals with glycemic levels above
250 mg/dl were considered for mating. After 3–7 days of diabetic
state conﬁrmation, the rats were caged overnight with a male.
Vaginal smears were taken the following morning and a positive
smear was considered as day 0 of gestation. All dams were housed
and fed individually with the same diet. After birth, each litter,
consisting of 6 male rats, was left with the mother for 21 days; if
the male number was not enough to complete 6, females were
used but discarded at weaning. Male pups from different mothers
were randomly divided into four subgroups: group CO (controls);
group DO (diabetic offspring); group CA (controls receiving 2%
L-arg solution dissolved in 2% sucrose in drinking water) and
group DA (diabetic offspring receiving L-arg solution dissolved in
2% sucrose in drinking water). A number of 5 rats were used for
each group. Rats in the CO and DO groups received a 2% sucrose-
only solution. The L-arg dose was similar to that used in a
previous study (Reckelhoff et al., 1997), and the sucrose solution
was used as a vehicle in order to improve L-arg ingestion.
Supplementation with the L-arg solution or the sucrose-only
solution began immediately after weaning and was continued
until the end of the experimental protocol. Study rats received
1.2 g L-arg/kg of body weight/day. Glycemia was measured in
newborn rats, 12 h after delivery, and in 12-h fasted adult rats,
every month. Arterial pressure was evaluated monthly, from
2 months of age, by tail plethysmography.
For protein excretion determination, rats were placed in
metabolic cages and a 24-h urine collection was performed.
Protein concentration was measured by precipitation with 3%
sulfosalicylic acid.
To assess the response to insulin, an insulin overload test was
performed in all the experimental groups. After 8 h of food
deprivation, 2 month-old rats were anesthetized (50 ml/kg keta-
mine and 20 ml/kg xylazine; 0.2 ml/100 g), and then insulin
(Humulin, Eli Lilly Indianapolis, 0.75 Unity/kg) was administered
into the penile vein. This test comprised 6 blood glucose measures
using test strips (Accu-check Advantage, Roche, Mannheim,
Germany) at baseline (before insulin administration), 4, 8, 12
and 16 min post-insulin application. Glucose measures were thenconverted into natural logarithm (Ln); the slope was calculated
using linear regression (time Ln (glucose)) and multiplied by
100 to obtain the glucose decay constant rate during the
insulin tolerance test (kITT) per minute (%/min). Tryglicerides
were determined by the GPO-PAP (Glycerol Phosphate Oxidase)
enzymatic test.
2.2. mRNA-expression levels
Kidney samples were quickly frozen in liquid nitrogen. Total RNA
was isolated from kidney tissue using TRizol Reagent (Invitrogen,
USA) methodology, and RNA concentration was determined by
spectrophotometer readings at an absorbance of 260 nm. First-strand
cDNA was synthesized using MML-V reverse transcriptase (Promega,
Madison, WI, USA). All experimental protocols of real-time PCR were
based on the manufacturer’s recommendations using the TaqMan
gold RT-PCR Core Reagents Kit (Applied Biosystems, Foster City, CA,
USA). Primers and probes to hypoxanthine-guanine phosphoribosyl-
transferase (HPRT) (Rn01527838_g1), TNF-a (Rn99999017_m1),
IL-1b (Rn00580432_m1), IL-6 (Rn00561420_m1) inducible Nitric
Oxide Synthase (iNOS) (Rn00561646_m1) and endothelial Nitric
Oxide Synthase (eNOS) (Rn02132634_s1) were purchased from
Applied Biosystems. Cycling conditions were as follows: 10min at
95 1C, followed by 45 cycles of 15 s at 95 1C and 1min at 60 1C. The
amount of the target gene was normalized ﬁrst to an endogenous
reference (HPRT) and then relative to a calibrator (CO group), using
the 2-DDCt method. Hence, mRNA levels were expressed as an n-fold
difference relative to the calibrator. Analyses were performed with
the Sequence Detection Software 1.9 (SDS).
2.3. Cytokine assay
A Bio-Plex assay kit (Bio-Rad Laboratories, Inc., Hercules, CA,
USA) was used to measure tumor necrosis factor (TNF)-a, inter-
leukin (IL)-1b, IL-6, IL-17, interferon (IFN)-g, macrophage inﬂam-
matory protein (MIP)-1 and leptin in kidney samples. The kit was
used according to the manufacturer’s instructions. The assay was
read on the Bio-Plex suspension array system, and the data were
analyzed using Bio-Plex Manager software version 4.0. Standard
curves ranged from 32,000 to 1.95 pg/ml. Total protein of kidney
tissue was measured and the results are indicated as pg of speciﬁc
molecule/ug of total protein.
2.4. Statistical analysis
All data were described as mean7S.E.M. Statistical evaluation
of the data was carried out using the t-test or the One Way
Analysis of Variance (ANOVA) followed by Tukey’s post-test.
A P-value lower than 0.05 was considered to be signiﬁcant. All
statistical analyses were performed with the aid of GraphPad
software (San Diego, CA, USA).3. Results
3.1. Effect of maternal diabetes and L-arginine supplementation on
body and kidney weights, glycemia, triglycerides levels, proteinuria
and blood pressure levels in offspring
No differences concerning kidney weight were observed among
all groups (data not shown). The values for body weight, blood
pressure, proteinuria, glycemia and triglycerides are depicted in
Tables 1 and 2. Regarding this last parameter, although there is no
difference between 2 month-old DO and CO groups, at the age of
6 months, the DO group showed higher levels of triglycerides, and
the administration of L-arg led to a signiﬁcant decrease of it both in
Table 1
Body weight, mean arterial blood pressure, triglycerides, 24 h proteinuria and glycemia in 2 month-old rats.
Groups Body weight (g) Systolic blood pressure (mmHg) Triglycerides (mg/dl) Proteinuria (mg/24 h) Glycemia (mg/dl)
CO 242.074.41 121.272.72 91.572.24 3.1570.72 100.174.22
CA 281.679.62 110.0771.19 44.570.71a 4.4270.9 92.4271.49
DO 228.675.67 150.7473.59a 90.575.5 9.8870.81a 112.473.59
DA 265.3713.4 112.4373.52b 54.071.2b 5.770.9 90.3373.07
Values are means7S.E.M.; n¼6–15.
a Signiﬁcance level Po0.05 vs. CO group.
b Signiﬁcance level Po0.05 vs. DO group.
Table 2
Body weight, mean arterial blood pressure, triglycerides, 24 h proteinuria and glycemia in 6 month-old rats.
Groups Body weight (g) Systolic blood pressure (mmHg) Triglycerides (mg/dl) Proteinuria (mg/24 h) Glycemia (mg/dl)
CO 449.778.89 110.3373.51 98.073.0 5.9670.58 102.072.69
CA 437.774.19 111.3571.19 47.071.5a 6.5370.54 109.473.10
DO 449.5712.28 159.8971.96a 154.7730.33a 4.970.3 115.375.43
DA 443.12 714.73 114.8674.47b 58.6776.5b 9.7571.1b 110.073.21
Values are means7S.E.M.; n¼6–12.
a Signiﬁcance level Po0.05 vs. CO group.
b Signiﬁcance level Po0.05 vs. DO group.
Fig. 1. Glycemic response to exogenous insulin in 2 month-old diabetic offspring,
with or without L-arg supplementation. Two month-old diabetic offspring shows a
blunted response to exogenous insulin. L-arginine reversed the insulin resistance
in DO animals, but had no effect in control animals. kITT¼glucose decay constant
rate. n¼5; *Po0.05.
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increased in 2 month-old DO rats, when compared to the CO group.
This proﬁle was maintained and even enhanced at six months. L-arg
administration did not change the blood pressure levels in CA
animals but caused a signiﬁcant decrease in DA group, at both ages.
As shown in Fig. 1, DO rats showed a signiﬁcantly blunted glycemic
response to exogenous insulin. In DA and CA groups, a normal
response to insulin was observed.
3.2. Expression of mRNA of cytokines in kidney.
We assessed the expression of inﬂammatory cytokines TNF-a,
IL-1b and IL-6, as well as iNOS and eNOS, by real-time PCR in the
kidneys. No signiﬁcant difference was observed in the gene
expression of TNF-a, IL-1b and IL-6, when comparing 2 month-
old DO rats to CO animals at the same age.
L-arg treatment promoted NOS expression, since iNOS and
eNOS expressions were signiﬁcantly higher in CA and DA groups,
when compared to CO and DO rats, respectively (Fig. 2). At six
months of age, the mRNA-expression levels of TNF-a, IL-1b and
IL-6 were signiﬁcantly higher in DO group than CO group, and as
in the younger group, the L-arg administration reduced the
expression of these inﬂammatory markers. For iNOS, both treatedgroups showed signiﬁcantly higher gene expression than
untreated ones. eNOS mRNA levels were signiﬁcantly higher
in the DA group when compared to the DO group (Fig. 3).
It is important to highlight that, when observing iNOS and
eNOS expression, DO group showed signiﬁcantly less gene
expression than CO group, which were restored by L-arg treat-
ment (Figs. 2 and 3).
3.3. Expression of cytokines, chemokines and hormone in renal
tissue.
Levels of TNF-a, IL-1b, IL-6, IL-17, IFN-g, MIP-1 and leptin were
quantiﬁed in the kidney of the offspring. For IL-1b and leptin, the
protein expression in 2 month-old DO group was not signiﬁcantly
different from those from CO animals. However, at this age, levels
of TNF-a, IL-6, IFN-g, MIP-1 and IL-17 were signiﬁcantly increased
in DO rats, and the L-arg treatment abolished this effect (Fig. 4).
In 6-month-old rats, all the inﬂammatory markers evaluated were
enhanced in the DO group, with the exception of IL-6; as observed
in two-month-old rats, the L-arg supplementation prevented this
increase (Fig. 5).4. Discussion
The present study indicates that activation of inﬂammatory
pathways is present early in the kidney from DO animals, and that
L-arg can attenuate these markers of tissue inﬂammation. More-
over, we reinforce the importance of intrauterine environmental
factors in determining metabolic disturbances in offspring.
In our model, the offspring was exposed to high glycemic
levels since conception, but the direct harmful effect of strep-
tozotocin to the fetus was avoided. Among the known changes
caused by sustained hyperglycemia, we can list some of the
main metabolic disturbances: increased production of reactive
oxygen species, impaired insulin action in vascular tone,
enhanced production of advanced glycosylation end-products,
lipid and protein abnormalities. All these metabolic changes
can occur during pregnancy, inducing fetal abnormalities
(Muniyappa et al., 2007).
The decline in triglyceride levels after L-arg deserves comment. It
is known that insulin resistance causes visceral fat accumulation,
Fig. 2. Expression of pro-inﬂammatory cytokines and NOS isoforms in the kidney from rats at 2 month-old. Tumor necrosis factor-alpha (TNF-a), interleukin (IL)-6, IL-1b,
iNOS and eNOS were measured by real time PCR in the kidney from 2 month-old rats. Although not signiﬁcant, an increase in gene inﬂammatory cytokines expression was
observed. The NOS isoforms showed signiﬁcantly higher gene expression than untreated ones. *Po0.05; n¼5.
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state. Drugs such as Fenoﬁbrate, which are used in hypertriglyceri-
demic patients, increase NO bioavailability (Koh et al., 2006). It is
possible that L-arg, acting as an anti-inﬂammatory agent, could
decrease triglyceride levels by improving the metabolic response to
insulin, as shown in Fig. 1.
Although we did not measure insulinemia, it is likely that
normal glycemic levels are the result of a stimulated secretion of
insulin. Hyperinsulinemia is usually present in other pathologic
situations, as in metabolic syndrome. The most widely accepted
hypothesis for beta-cell disfunction during diabetic pregnancy is
that increased free radical reactive oxygen species induce
damage to the developing fetus, resulting in both early and late
metabolic disturbances. Insulin resistance is characterized by
pathway-speciﬁc impairment in phosphatidylinositol 3-kinase-
dependent signaling that in vascular endothelium contributes
to a reciprocal relationship between insulin resistance and
endothelial dysfunction (Muniyappa et al., 2007). The clinical
importance of this connection is the ﬁnding that speciﬁc ther-
apeutic interventions targeting insulin resistance often improve
endothelial function (and vice versa). L-arg supplementation has
shown protective effects in a model of sucrose-induced insulinresistance in rats, decreasing the hyperlipidemia and the insulin
resistance (Monti et al., 2008). In our present study, insulin
resistance and blood pressure levels returned to normal levels
in DO rats treated with L-arg, reinforcing the role of NO in
our model.
In the present study, we have conﬁrmed that, in the DO model,
there is a clear resistance to insulin in the young offspring,
associated with increased pro-inﬂammatory cytokines levels. In
fact, insulin resistance is associated with chronic activation of the
innate immune system (Ehses et al., 2009). Moreover TNF-alpha
and IL-6 are positively correlated with insulin resistance, and
these cytokines can impair biological effects of insulin in skeletal
muscle and adipose tissue (Emanuelli et al., 2001; Monroy et al.,
2009; Nieto-Vazquez et al., 2008).
In this study, we could demonstrate that the protein expres-
sion of some inﬂammatory cytokines was already increased in
2 month-old DO animals, suggesting that the inﬂammatory
process can be triggered early in offspring life, at a time when
kidney injury has not been detected. This can be suggested by the
normal levels of proteinuria, since in rats, only values above
15 mg/24 h are considered signiﬁcantly elevated (Suzuki et al.,
2006). However, at this age, DO group has already shown an
Fig. 3. Expression of pro-inﬂammatory cytokines and NOS isoforms in the kidney from rats at six months of age. Tumor necrosis factor-alpha (TNF-a), interleukin (IL)-6, IL-
1b, iNOS and eNOS were measured by real time PCR in the kidney from six months of age rats. At six months of age, the expression of TNF-a, IL-1b and IL-6 was
signiﬁcantly higher in DO than CO rats, and the L-arg administration reduced the expression of these inﬂammatory markers. For iNOS, both treated groups showed
signiﬁcantly higher gene expression than untreated ones. For eNOS, the DA group showed signiﬁcantly higher mRNA expression than DO group. *Po0.05; n¼5.
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and hypertension linked to decreased vascular NO (Cavanal Mde
et al., 2007; Magaton et al., 2007; Potenza et al., 2005) which
altogether, could characterize hypertension linked to insulin
resistance and to oxidative stress. In the older group, the inﬂam-
matory mechanism persists and other inﬂammatory cytokines are
detected, suggesting that aging could amplify this process. Rocha
et al. (2005) has found that a signiﬁcant decrease in nephron
number is only seen in 12 month-old DO animals, while at six
months of age the glomeruli count is within normal range (Rocha
et al., 2005). This change in nephron number in older rats could
be, at least, explained by an exacerbated inﬂammatory response,
since pro-inﬂammatory cytokines are important mediators of
tissue damage and long-term exposure to molecules, such as
TNF-a, induces glomerular endothelial cells apoptotic death
(Messmer et al., 1999, 2000).
The increased production of inﬂammatory cytokines was
demonstrated to play an important role in the development and
progression of diabetic nephropathy (Matavelli et al., 2010;
Navarro-Gonzalez and Mora-Fernandez, 2008). But as far as we
know, this is the ﬁrst study demonstrating the involvement of
inﬂammatory markers in the kidney of offspring from diabetic
mothers and the beneﬁcial effects of L-arg.Several studies have shown that NO promotes inﬂammation
(Kroncke et al., 2001; Langrehr et al., 1993), whereas an equal
number of studies demonstrate an anti-inﬂammatory role,
decreasing production of inﬂammatory molecules (Angele et al.,
1999; Meldrum et al., 1997). These conﬂicting results may be due
to concentration-dependent effects of NO, the variety of in vivo or
in vitro experimental models, and/or differences in cell sensitivity
to NO. In our study, L-arg showed an anti-inﬂammatory role, and
decreased the protein expression of TNF-a, IFN-g, MIP-1, IL-6 and
IL-17 in 2 month-old DO group, and TNF-a, IFN-g, MIP-1, IL-1b,
IL-2, IL-17 and leptin in 6 month-old age DO rats. Gene over-
expression of TNF-a, IL-1b and IL-6 observed in DO animals was
also attenuated by L-arg, suggesting that diabetic offspring may
represent an experimental model where an overall inﬂammatory
state is present.
Some of the up-regulated molecules present in the DO group
have been linked to metabolic disease. IL-17 has been associated
to renal inﬂammation and other metabolic disorders, and its
presence leads to a worse prognosis of the disease (Ahmed and
Gaffen, 2010; Kitching and Holdsworth, 2011; Pini and Fantuzzi,
2010; Shin et al., 2009; Turner et al., 2010; Winer et al., 2009). The
Th1 pattern molecule IFN-g has been described as an important
mediator of ‘‘fat inﬂammation’’, and its presence leads to an
Fig. 4. Pro-inﬂammatory cytokines in the kidney from rats at 2 month-old. All molecules were quantiﬁed by Bioplex. At 2 month-old, DO rats did not differ from CO rats in
interleukin (IL)-1b and leptin protein expression. Renal levels of tumor necrosis factor-alpha (TNF-a), IL-6, interferon (IFN)-g, macrophage inﬂammatory protein (MIP)-1
and IL-17 were signiﬁcantly increased in DO rats, and the L-arg treatment prevented this effect. *Po0.05; n¼5. ND¼not detectable.
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kines and TNF-a. Moreover, leptin is produced mainly in adipose
tissue, and acts as a pro-inﬂammatory adipokine. Studies with
leptin showed its capacity of inducing pro-inﬂammatory
cytokines (Loffreda et al., 1998), and stimulating chemotaxis in
polymorphonuclear cells (Brennan and Mantzoros, 2006;
Caldeﬁe-Chezet et al., 2003). Furthermore, leptin promotes Th1
cell differentiation and cytokine production (Matarese et al.,
2005). All these data corroborate our results and conﬁrm our
idea that, in our model, L-arg has an anti-inﬂammatory property.
The renal cells, as a response to the environmental changes,
might initiate the production of the several cytokines, promoting
inﬂammation. Later, there must occur the recruitment of immune
cells, which will increase and exacerbate the inﬂammatory
process. The recruitment of immune cells is evident when weobserve the presence of the chemokine MIP-1 in renal tissue.
Among such cells, we could imagine that the M1 macrophages, or
classically activated macrophages, may contribute to the disease,
as they are known as inﬂammatory macrophages. In this sense,
probably there is also a decrease in M2 macrophages. As these
macrophages have a well known anti-inﬂammatory proﬁle, the
lack of them probably inﬂuences the pro-inﬂammatory environ-
ment (Anders and Ryu, 2011).
Furthermore, talking about the reduced expression of inﬂam-
matory markers after L-arg supplementation, Tousoulis and col-
leagues have shown that supplementation of L-arg in high risk
patients increased NO production and reduced leukocyte adhe-
sion (Tousoulis et al., 2007). Moreover, Michell and colleagues
suggest that high blood pressure induces increase in reactive
oxygen species production in endothelial cells that will promote
Fig. 5. Pro-inﬂammatory cytokines in the kidney from rats at six months of age. All molecules were quantiﬁed by Bioplex. At six months of age, tumor necrosis factor-
alpha (TNF)-a, interleukin (IL)-1b, IL-17, interferon (IFN)-g, macrophage inﬂammatory protein (MIP)-1 and leptin enhanced in DO group and the L-arg supplementation
prevented this increase. *Po0.05; n¼5.
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ability and consequently NO production. The uncoupled eNOS
produces superoxide, instead of NO, resulting in the production of
pro-inﬂammatory factors that leads to the expression of adhesion
molecules, promoting inﬂammation (Michell et al., 2011) So, L-arg
supplementation could reverse this cascade, attenuating the
inﬂammatory process.
Also, it is important to highlight that the difference observed
on gene expression of iNOS and eNOS between CO and CA
groups proved that the L-arg treatment was able to up regulate
the NOS isoforms, which led us to the conclusion that the
protection observed must be, at least in part, due to higher NO
availability.Experiments with aortic rings of genetic diabetic-prone rats,
demonstrated that there was a limitation in the utilization of
L-arg, either by compartmentalization or limitation in a cofactor
for NO synthase, contributing to decreased NO production in the
endothelium. Thus, the mechanism of the L-arg effect on impaired
endothelium-dependent relaxation in diabetic blood vessels could
be due to NO reduction (Pieper et al., 1997). Our results suggest
that these mechanisms could be involved in our model, as we
observed less inﬂammation in treated animals.
In conclusion, we can suggest that activation of inﬂammatory
pathways is present at early age in the kidney of DO animals and
that L-arg can attenuate these markers of tissue inﬂammation.
Moreover, the DO rats can represent a suitable model of
M. Correa-Costa et al. / European Journal of Pharmacology 689 (2012) 233–240240hypertension with kidney involvement, similar to SHR and Dahl
rats. Our results also reinforce the concept that intrauterine
environmental factors can deﬁne the metabolic characteristics
of the offspring, being a fundamental determinant in the devel-
opment of metabolic and vascular diseases later in life.Acknowledgments
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